Tilray Brands Inc
TLRY: XTSE (CAN)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|.gl?pDS@ | LOCK|M#Q | LOCK|&B%h@h |
Tilray Earnings: Strategic Moves Offer Some Help to Challenged Cannabis, but Alcohol Struggles
Tilray reported fiscal fourth-quarter 2025 results, with net revenue declining 2% year over year to $224.5 million. Cannabis revenue declined by 6%, while alcoholic beverages plunged 14%. Adjusted EBITDA margins declined about 50 basis points to 12.3%.
